News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation
Thursday, October 10, 2024Pharming Group NV announces the start of a Phase II proof of concept clinical trial evaluating leniolisib in primary immunodeficiencies PIDs with immune dysregulation linked to altered PIK signaling in lymphocytes The clinical trial is open for enrol...
Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals
Wednesday, October 09, 2024Tonix Pharmaceuticals Holding Corp a fullyintegrated biopharmaceutical company with marketed products and a pipeline of development candidates today announced that it has entered into an AI and ML research collaboration with XChem Inc XChem a leader...
Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002
Wednesday, October 09, 2024Oragenics Inc a company focused on developing new treatments for brainrelated health conditions has completed a key study for their new concussion drug ONP This drug is designed to be delivered through the nose which could help it reach the brain qui...
NMDP BioTherapies℠ Relaunches Premium Services Supporting Autologous Cell Therapies
Tuesday, October 08, 2024NMDP BioTherapies formerly known as the Be The Match BioTherapies a leader in cell and gene therapy development support announced today it is relaunching an improved suite of premium services for developers of autologous cell and gene therapies in re...
Orchard Therapeutics and Er-Kim Announce Partnership to Broaden Access to Libmeldy to Eligible Patients in Turkey and Certain Eurasian Countries
Tuesday, October 08, 2024Orchard Therapeutics recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe and ErKim an international pharmaceutical company specializing in the commercialization of novel thera...
IMU Biosciences joins ground-breaking UK research consortium investigating patient response to cancer immunotherapies
Monday, October 07, 2024IMU Biosciences a biotechnology company pioneering systemslevel immune profiling with AI to drive breakthroughs in precision medicine is pleased to announce its participation in MANIFEST Multiomic ANalysis of Immunotherapy Features Evidencing Success...
Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda
Monday, October 07, 2024The Sabin Vaccine Institute has provided its investigational Marburg vaccine to Rwanda to support the ongoing outbreak response The initial shipment of approximately vaccine doses will be used in a trial targeting frontline workers including healthc...
Orbis Medicines to Expand With New R&D Site in Copenhagen
Friday, October 04, 2024Orbis Medicines a leader in oral macrocycle drug discovery today announced a significant expansion of its operations and capabilities by establishing itself at Symbions new biotech hub in Fuglebakken Copenhagen Symbion is Denmarks largest startup eco...
Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility
Friday, October 04, 2024Ferring Pharmaceuticals announced the opening of a stateoftheart global manufacturing hub in Finland for the drug substance of its intravesical nonreplicating gene therapy Adstiladrin nadofaragene firadenovecvncg This represents a significant milesto...
Xcell Biosciences Expands AmplifyBio Collaboration with Unique Cell and Gene Therapy Manufacturing Capabilities
Thursday, October 03, 2024Xcell Biosciences Inc Xcellbio an instrumentation company focused on cell and gene therapy applications today announced that it has expanded its collaboration with AmplifyBio a rapidly growing contract development and manufacturing organization throu...
